General Experimental Methods
All reactions were carried out under argon atmosphere. Stirring was achieved with oven-dried magnetic stir bars. Et 2 O and CH 2 Cl 2 were purified by passage through the Solv-Tek purification system employing activated Al 2 O 3 (Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Safe and Convenient Procedure for Solvent Purification Organometallics 1996, 15, 1518-1520). CHCl 3 was passed through basic alumina and dried over molecular sieves. Et 3 N was purified by passage through basic alumina or distilled over CaH 2 and stored over KOH. Flash column chromatography was performed with SiO 2 from Mallinckrodt Chemicals (V120-25, Silica gel, 60 A, 40-63 µm). Crude mixture was also purified using a Biotage® Isolera automated flash column chromatography system. Thin layer chromatography was performed on silica gel 60F 254 plates (EMD-5715-7, Merck. For Celite-SPE 6 mL empty cartridges were purchased from Silicycle Inc. (www.silicycle.com/). Deuterated solvents were purchased from Cambridge Isotope laboratories. 1 H, 13 C NMR spectra were recorded on a Bruker DRX-400 spectrometer operating at 400 MHz, 100 MHz respectively as well as a Bruker DRX-500 spectrometer operating at 500 MHz, 125 MHz respectively. Gas chromatography (GC) was performed using an Agilent Technologies 6890N with data processing on a Dell desktop. GC/mass spectrometry was performed using a Quattro micro GC (Micromass UK Limited). Highresolution mass spectrometry (HRMS) was recorded on a LCT Premier Spectrometer (Micromass UK Limited) operating on ESI (MeOH). FTIR spectroscopy was performed using a Shimadzu FTIR-8400S instrument.
General procedure for silica oligomeric heterocyclic benzyl phosphate (Si-OHBP n ) and triazole phosphate (Si-OHTP n )
Si-Nb (load ~0.4 mmol/g, 1 equiv.) was heated with C848 (G-II) (0.2 equiv.) at 45 ºC in dichloromethane for 2 hrs under argon. The OHBP or OHTP monomer was added (50 equiv. w/r to cat. G-II) in CH 2 Cl 2 and toluene to the reaction mixture and heated at 45 ºC for overnight. The reaction mixture was cooled to room temperature and EVE was added, and then stirred for an additional 1 hour at room temperature. The reaction mixture was filtered and washed with mixture of toluene:CH 2 Cl 2 (1:1), and dried over high vacuo pump.
Procedure A: General procedure for different nucleophilic substitution with Si-OHBP n
To a 1-dram vial w/teflon cap was added Si-OHBP 7a or 7b (1.5 equiv.) followed by addition of sodium iodide (0.2 equiv.), Cs 2 CO 3 (3.0 equiv.), and solvent THF (0.2 M). The mixture was stirred rapidly followed by subsequent addition of different nucleophiles. The reaction was sealed under argon and heated to 80 ºC w/stirring for 12-14 hrs. After such time the reaction was cooled to rt and crude mixture was then filtered via celite packed 6 mL SPE and rinsed several times with a mixture of hexanes:EtOAc (1:2). The resulting eluent was then concentrated in vacuo to yield the hetero-benzylated products in good to excellent yields and purities. 
8a-8i
R 1 = 3-pyridyl (7a) 4-pyridyl (7b) N X R 2 N OR n Si O P O O O N N N R 1 1) R 2 -XH,
SI-3
SPE and rinsed with a mixture of hexanes:EtOAc (1:2). The resulting eluent was then concentrated in vacuo to yield the products in good to excellent yields and purities.
(5aR,6R,9S,9aS)-3-(pyridin-3-ylmethoxy)-1,5,5a,6,9,9a-hexahydro-6,9- Compound 3b (1.9 g, 6.1mmol, 60%) was isolated as a brown solid.
MP: 110 ºC.
FTIR (neat, cm -1 ): 3446, 3058, 2966, 2850, 1604, 1564, 1415, 1288, 1064, 1035 
SI-4
Compound 4a (0.38 g, 0.978 mmol, 83%) was isolated as white solid. 
MP: 154 ºC

3-((4-(tert-butyl)phenoxy)methyl)pyridine (8a)
Utilizing general procedure A, 8a (19.5 mg, 0.08mmol, 97%) was isolated as a light brown solid.
MP: 53 ºC.
FTIR (neat, cm -1 ): 2958, 1605, 1585, 1518, 1294, 1242, 1182, 827 ;
.84 (dd, J = 7.9, 4.9 Hz, 1H), 7.38 (dd, J = 7.9, 4.9
Hz, 1H), 7.35-7.31 (m, 2H), 6.92 (d, J = 8.8 Hz, 2H), 5.10 (m, 2H), 1.31 (s, 9H). 
C NMR
3-(((3,4-dimethoxyphenyl)thio)methyl)pyridine (8c)
Utilizing general procedure A, 8c (16 mg, 0.061 mmol, 70%) was isolated as a yellow thick liquid. 
4-((4-(tert-butyl)phenoxy)methyl)pyridine (8d)
Utilizing general procedure A, 8d (19 mg, 0.078 mmol, 98%) was isolated as a brown liquid.
FTIR (neat, cm -1 ): 2958, 2904, 2866, 1606, 1502, 1413, 1244, 1182, 827; 
S)-3-benzyl-7-bromo-2-(pyridin-3-ylmethyl)-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide (8f)
Utilizing general procedure A, 8f (25mg, 0.054 mmol, 99%) was isolated as a white solid. 7-bromo-3-isobutyl-2-(pyridin-3-ylmethyl)-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1- 
SI-7 (S)-
(S)-3-benzyl-7-bromo-2-(pyridin-4-ylmethyl)-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide (8h)
Utilizing general procedure A, 8h (18 mg, 0.039 mmol, 97%) was isolated as a yellow solid.
MP: 179 ºC.
FTIR (neat, cm -1 ): 3085, 3026, 2958, 2921, 1602, 1579, 1538, 1323, 1153 128.9, 128.8, 127.8, 127.3, 127.1, 126.9, 124.9, 123.5, 74.2, 64.3, 53.9, 36.9 . FTIR (neat, cm -1 ): 2960, 2852, 2358, 1600, 1577, 1538, 1460, 1340, 1161, 1024 
3-((4-(((2,4,6-trichlorophenyl)thio)methyl)-1H-1,2,3-triazol-1-yl)methyl)pyridine (9a)
Utilizing general procedure B, 9a (47 mg, 0.121 mmol, 88%) was isolated as a brown thick liquid. 144.3, 135.6, 134.9, 132.4, 131.5, 130.7, 130.7, 130.3, 129.9, 124.0, 122.1, 51.7, 27.7 .
HRMS calculated for C 15 H 12 Cl 3 N 4 S (M+H) + 384.9848; found 384.9813 (TOF MS ES+).
3-((4-((2,4-dichlorophenoxy)methyl)-1H-1,2,3-triazol-1-yl)methyl)pyridine (9b)
Utilizing general procedure B, 9b (57 mg, 0.170 mmol, 93%) was isolated as a colorless thick liquid. 5, 150.4, 149.1, 144.3, 135.7, 130.3, 130.1, 127.7, 126.6, 124.1, 124.0, 122.8, 115.1, 63.5, 51.7 . 
SI-9
Utilizing general procedure B, 9c (36 mg, 0.071 mmol, 81%) was isolated as a thick liquid. : 2958, 2358, 2341, 1579, 1558, 1458, 1423, 1373, 1323, 1164, 1081 150.4, 149.2, 144.3, 135.6, 131.6, 130.2, 130.0, 127.5, 126.6, 125.4, 123.9, 123.4, 77.2, 73.8, 59.9, 51.6, 38.7, 24.6, 22.8, 22 .0. 
FTIR (neat)
HRMS
4-((4-(((2,4,6-trichlorophenyl)thio)methyl)-1H-1,2,3-triazol-1-yl)methyl)pyridine (9d)
Utilizing general procedure B, 9d (45 mg, 0.116 mmol, 84%) was isolated as a brown thick liquid. (neat): 2923, 2850, 2283, 1635, 1473, 1274, 1259, 1110, 1024 149.8, 143.8, 137.4, 135.1, 132.4, 131.5, 130.7, 130.5, 129.9, 123.5, 122.9, 122.3, 55.7, 27.8 
FTIR
4-((4-(((3,4-dimethoxyphenyl)thio)methyl)-1H-1,2,3-triazol-1-yl)methyl)pyridine (9e)
Utilizing general procedure B, 9e (53 mg, 0.155 mmol, 89%) was isolated as a white solid. (neat): 2952, 1581, 1502, 1438, 1253, 1228, 1135, 1024 4, 148.6, 145.2, 134.9, 129.1, 128.7, 127.6 (2C), 125.6, 124.7, 121.4, 115.8, 111.7, 55.9, 55.8, 54.2, 30.6 . 
FTIR
4-((4-((2,4-dichlorophenoxy)methyl)-1H-1,2,3-triazol-1-yl)methyl)pyridine (9f)
Utilizing general procedure B, 9f (53 mg, 0.158 mmol, 87%) was isolated as a colorless thick liquid.
FTIR (neat): 2929, 2850, 2358, 2088, 1639, 1448, 1274, 1259, 1135, 1105, 1049 152.6, 149.9, 143.9, 137.4, 130.1, 127.7, 126.5, 124.0, 123.6, 123.6, 122.5, 115.2, 63.5, 55.7 . 6R,9S,9aS)-3-(pyridin-3-ylmethoxy)-1,5,5a,6 ,9,9a-hexahydro-6,9- 6R,9S,9aS)-3-(pyridin-4-ylmethoxy)-1,5,5a,6,9,9a-hexahydro-6 6R,9S,9aS)-3-((1-(pyridin-3-ylmethyl)-1H-1,2,3-triazol-4-yl)methoxy)1,5,5a,6,9,9a-hexahydro-6 6R,9S,9aS)-3-((1-(pyridin-4-ylmethyl)-1H-1,2,3-triazol-4-yl)methoxy)-1,5,5a,6,9,9a-hexahydro-6 -(((2,4,6-trichlorophenyl) 7-bromo-3-isobutyl-2-(pyridin-3-ylmethyl)-3,4-dihydro-2H-benzo[b][1,4,5] 3-benzyl-7-bromo-2-(pyridin-4-ylmethyl)-3,4-dihydro-2H-benzo[b][1,4,5] 7-bromo-3-methyl-2-(pyridin-3-ylmethyl)-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine-1,1- 4-(((2,4,6-trichlorophenyl)thio)methyl)-1H-1,2,3-triazol-1-yl) 4-((2,4-dichlorophenoxy)methyl)-1H-1,2,3-triazol-1-yl) 7-bromo-3-isobutyl-2-((1-(pyridin-3-ylmethyl)-1H-1,2,3-triazol-4-yl)methyl)-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide (9c 4-(((2,4,5-trichlorophenyl)thio)methyl)-1H-1,2,3-triazol-1-yl) -(((3,4-dimethoxyphenyl)thio)methyl)-1H-1,2,3-triazol-1-yl) 4-((2,4-dichlorophenoxy)methyl)-1H-1,2,3-triazol-1-yl) 
HRMS
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